Your browser doesn't support javascript.
loading
Impact of SF3B1 mutation in myelofibrosis.
Senapati, Jayastu; Verstovsek, Srdan; Masarova, Lucia; Pemmaraju, Naveen; Patel, Keyur P; Montalban-Bravo, Guillermo; Pierce, Sherry A; Zhou, Lingsha; Garcia-Manero, Guillermo; Kantarjian, Hagop M; Bose, Prithviraj.
Afiliación
  • Senapati J; Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA.
  • Verstovsek S; Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA.
  • Masarova L; Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA.
  • Pemmaraju N; Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA.
  • Patel KP; Department of Hematopathology, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA.
  • Montalban-Bravo G; Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA.
  • Pierce SA; Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA.
  • Zhou L; Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA.
  • Garcia-Manero G; Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA.
  • Kantarjian HM; Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA.
  • Bose P; Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA.
Leuk Lymphoma ; 63(11): 2701-2705, 2022 11.
Article en En | MEDLINE | ID: mdl-35787095

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Mielofibrosis Primaria / Factores de Empalme de ARN Tipo de estudio: Diagnostic_studies Límite: Humans Idioma: En Revista: Leuk Lymphoma Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Mielofibrosis Primaria / Factores de Empalme de ARN Tipo de estudio: Diagnostic_studies Límite: Humans Idioma: En Revista: Leuk Lymphoma Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos